You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ALBUTEROL SULFATE; BUDESONIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for albuterol sulfate; budesonide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT03772223 ↗ A Study to Compare the Pharmacokinetics of Budesonide and Albuterol Delivered by PT027 Compared With PT007 and PT008 Administered Separately. Completed AstraZeneca Phase 1 2019-01-21 This is a Phase 1 study to compare the pharmacokinetics of budesonide and albuterol delivered by PT027 compared with PT007 and PT008 administered separately.
NCT03934333 ↗ A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS) Completed AstraZeneca Phase 1 2019-05-16 This study is to compare the systemic exposure of budesonide delivered by the combination inhaler (budesonide/albuterol sulfate pressurized inhalation suspension [BDA metered dose inhaler {BDA MDI}]) with Pulmicort Flexhaler dry-powder inhaler (DPI).
NCT05505734 ↗ A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma Not yet recruiting Parexel Phase 3 2022-08-17 This is a US study comparing the efficacy and safety of BDA MDI [Budesonide/Albuterol Sulfate (BDA) metered dose inhaler (MDI)] with AS [Albuterol Sulfate] MDI, both are administered as needed for up to 12 months.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for albuterol sulfate; budesonide

Condition Name

Condition Name for albuterol sulfate; budesonide
Intervention Trials
Asthma 1
Healthy Volunteers 1
Relative Bioavailability 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for albuterol sulfate; budesonide
Intervention Trials
Asthma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for albuterol sulfate; budesonide

Trials by Country

Trials by Country for albuterol sulfate; budesonide
Location Trials
United Kingdom 1
United States 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for albuterol sulfate; budesonide
Location Trials
Maryland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for albuterol sulfate; budesonide

Clinical Trial Phase

Clinical Trial Phase for albuterol sulfate; budesonide
Clinical Trial Phase Trials
Phase 3 1
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for albuterol sulfate; budesonide
Clinical Trial Phase Trials
Completed 2
Not yet recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for albuterol sulfate; budesonide

Sponsor Name

Sponsor Name for albuterol sulfate; budesonide
Sponsor Trials
AstraZeneca 2
Parexel 1
Bond Avillion 2 Development LP 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for albuterol sulfate; budesonide
Sponsor Trials
Industry 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.